Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastoma
Abstract Oncolytic viruses (OVs) emerge as a promising cancer immunotherapy. However, the temporal impact on tumor cells and the tumor microenvironment, and the nature of anti-tumor immunity post-therapy remain largely unclear. Here we report that CD4+ T cells are required for durable tumor control...
Hlavní autoři: | , , , , , , , , |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Nature Portfolio
2025-01-01
|
Edice: | Nature Communications |
On-line přístup: | https://doi.org/10.1038/s41467-024-55455-9 |